Storyline
Moderna will pay $950 million upfront—and no future royalties—to settle patent litigation over its mRNA-based vaccine Spikevax. The case was brought by Roiva...
Moderna agrees $950m settlement of mRNA jab litigation Phil.Taylor Wed, 04/03/2026 - 13:19.
Current brief openSource links open
This current storyline is open here with summary, metadata, source links, continuity context, and full evidence. Paid is for compare-over-time, alerts, exports, and workflow.
No card needed for the free brief.
Evidence trail (top sources)
top sources (3 domains)domains are deduped. counts indicate coverage, not truth.3 top sources shown
Overview
Moderna agrees $950m settlement of mRNA jab litigation Phil.Taylor Wed, 04/03/2026 - 13:19.
Score total
1.59
Momentum 24h
4
Posts
4
Origins
3
Source types
2
Duplicate ratio
25%
Continuity snapshot
- Trend status: insufficient_history.
- Continuity stage: emerging_confirmed.
- Current status: open.
- 4 current source-linked posts are attached to this storyline.
All evidence
All evidence
Moderna to pay up to $2.25B to end mRNA vaccine patent fight
BioPharma Dive · biopharmadive.com · 2026-03-04 17:06 UTC
Moderna will pay $950 million upfront—and no future royalties—to settle patent litigation over its mRNA-based vaccine Spikevax. The case was brought by Roivant subsidiary Geneva...
Fierce Pharma (All) · fiercepharma.com · 2026-03-04 15:37 UTC
Moderna agrees $950m settlement of mRNA jab litigation
pharmaphorum · pharmaphorum.com · 2026-03-04 13:19 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 3Origin domains: 3Duplicates: -
Showing 3 / 0
Top publishers (this list)
- BioPharma Dive (1)
- Fierce Pharma (All) (1)
- pharmaphorum (1)
Top origin domains (this list)
- biopharmadive.com (1)
- fiercepharma.com (1)
- pharmaphorum.com (1)